Emerging infections of the central nervous system

Current Infectious Disease Reports

Volumn 15, Issue 6, 2013, Pages 576-582

  Lyons, Jennifer ^a,b   McArthur, Justin ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Arbovirus; Borrelia miyamotoi; CNS tuberculosis; Cycloviruses; Dengue; Eastern equine encephalitis; Emerging infections; Encephalitis; Henipavirus; HIV 2; La Crosse virus; Poliomyelitis; Powassan virus; Tick borne encephalitis virus; Tuberculous meningitis; West Nile virus

Indexed keywords

CEFTRIAXONE; DRUG RESISTANT TUBERCULOUS MENINGITIS; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG;

ANAMNESIS; ARTICLE; BACTERIAL MENINGITIS; BORRELIA INFECTION; BORRELIA MIYAMOTOI; CALIFORNIA ENCEPHALITIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CHIKUNGUNYA ALPHAVIRUS; CIRCOVIRIDAE INFECTION; CYCLOVIRUS; DENGUE; DENGUE VIRUS; DRUG RESISTANT TUBERCULOSIS; ENCEPHALITIS; ENDEMIC DISEASE; FLACCID PARALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2 ENCEPHALITIS; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); LA CROSSE VIRUS; MENINGOENCEPHALITIS; MORBIDITY; MORTALITY; MYCOSIS; MYELITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLIOMYELITIS; POLIOMYELITIS VIRUS; RADICULITIS; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TUBERCULOUS MENINGITIS; UNITED STATES; VIRUS ENCEPHALITIS; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

EID: 84890758367     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0377-6     Document Type: Article

References (58)

1. West nile virus disease and other arboviral diseases - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:510-514.
2. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012;25:635-48.
3. Cho H, Diamond MS. Immune responses to West Nile virus infection in the central nervous system. Viruses. 2012;4:3812-30.
4. CDC. West Nile Virus Disease Cases and Deaths Reported to CDC by Year and Clinical Presentation, 1999-2012 [online]. Available at: http://www.cdc.gov/ westnile/resources/pdfs/cummulative/99-2012- CasesAndDeathsClinicalPresentationHumanCases.pdf. Accessed June 26, 2013.
5. Petersen L. Record heat may have contributed to a banner year for West Nile virus. Interview with Lyle Petersen. JAMA. 2012;308:1846-8.
6. Roehr B. Texas records worst outbreak of West Nile virus on record. BMJ. 2012;345:e6019.
7. Wang H, Siddharthan V, Kesler KK, et al. Fatal neurological respiratory insufficiency is common among viral encephalitides. J Infect Dis. 2013;208:573-83.
8. Barzon L, Pacenti M, Franchin E, et al. Excretion of West Nile virus in urine during acute infection. J Infect Dis. 2013.
9. Nolan MS, Podoll AS, Hause AM, et al. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS One. 2012;7:e40374.
10. Kaiser J. Public health. Outbreak pattern stymies vaccine work. Science. 2012;337:1030.
11. Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-9.
12. Ruzek D, Dobler G, Niller HH. May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis? BMC Infect Dis. 2013;13:306.
13. Brown CM, DeMaria Jr A. The resurgence of West Nile virus. Ann Intern Med. 2012;157:823-4.
14. Luz PM, Vanni T, Medlock J, et al. Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet. 2011;377:1673-80.
15. Fukunaga M, Takahashi Y, Tsuruta Y, et al. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol. 1995;45:804-10.
16. Branda JA, Rosenberg ES. Borrelia miyamotoi: a lesson in disease discovery. Ann Intern Med. 2013;159:61-2.
17. Platonov AE, Karan LS, Kolyasnikova NM, et al. Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. 2011;17:1816-23.
18. Krause PJ, Narasimhan S, Wormser GP, et al. Human Borrelia miyamotoi infection in the United States. N Engl J Med. 2013;368:291-3.
19. Gugliotta JL, Goethert HK, Berardi VP, Telford 3rd SR. Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med. 2013;368:240-5.
20. Heinz FX, Stiasny K, Holzmann H, et al. Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis. 2013;19:69-76.
21. Kunze U. Tick-borne encephalitis - a notifiable disease: report of the 15th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Ticks Tick Borne Dis. 2013.
22. West nile virus and other arboviral diseases - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:513-517.
23. Sung SWA, Shittier S, Kulas K, Kramer LD, Flam R, Roberts JK, et al. Powassan Meningoencephalitis, New York City, USA. Emerg Infect Dis. 2013;19:(ahead of print).
24. Amato-Gauci A, Zeller H. Tick-borne encephalitis joins the diseases under surveillance in the European Union. Euro Surveill. 2012;17.
25. Gottlieb GS, Eholie SP, Nkengasong JN, et al. A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS. 2008;22:2069-72. discussion 2073-2064.
26. Moulignier A, Lascoux C, Bourgarit A. HIV type 2 demyelinating encephalomyelitis. Clin Infect Dis. 2006;42:e89-91.
27. Wood BR, Klein JP, Lyons JL, et al. HIV-2 encephalitis: case report and literature review. AIDS Patient Care STDS. 2012;26:383-7.
28. Campbell-Yesufu OT, Gandhi RT. Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis. 2011;52:780-7.
29. Hollenbeck BL, Beckwith CG. HIV-2 infection in Providence, Rhode Island from 2002 to 2011. HIV Med. 2013;14:115-9.
30. le Tan V, van Doorn HR, Nghia HD, et al. Identification of a new cyclovirus in cerebrospinal fluid of patients with acute central nervous system infections. MBio. 2013;4:e00231-00213.
31. Smits SL ZE, van Hellemond JJ, Schapendonk CME, Bodewes R, Schürch AC, et al. Novel cyclovirus in human cerebrospinal fluid, Malawi, 2010-2011. Emerg Infect Dis. [Internet] 2013.
32. Fuchigami T, Imai Y, Hasegawa M, et al. Acute encephalopathy with pandemic (H1N1) 2009 virus infection. Pediatr Emerg Care. 2012;28:998-1002.
33. Okumura A, Tsuji T, Kubota T, et al. Acute encephalopathy with 2009 pandemic flu: comparison with seasonal flu. Brain Dev. 2012;34:13-9.
34. Simon M, Hernu R, Cour M, et al. Fatal Influenza A(H1N1)pdm09 encephalopathy in immunocompetent man. Emerg Infect Dis. 2013;19:1005-7.
35. Lee N, Ison MG. Diagnosis, management and outcomes of adults hospitalized with influenza. Antivir Ther. 2012;17:143-57.
36. Salmon DA, Proschan M, Forshee R, et al. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461-8.
37. Poland GA, Poland CM, Howe CL. Influenza vaccine and Guillain-Barre syndrome: making informed decisions. Lancet. 2013;381:1437-9.
38. Snary EL, Ramnial V, Breed AC, et al. Qualitative release assessment to estimate the likelihood of henipavirus entering the United Kingdom. PLoS One. 2012;7:e27918.
39. Marsh GA, Wang LF. Hendra and Nipah viruses: why are they so deadly? Curr Opin Virol. 2012;2:242-7.
40. Prescott J, de Wit E, Feldmann H, Munster VJ. The immune response to Nipah virus infection. Arch Virol. 2012;157:1635-41.
41. Nakka P, Amos GJ, Saad N, Jeavons S. MRI findings in acute Hendra virus meningoencephalitis. Clin Radiol. 2012;67:420-8.
42. Sazzad HM, Hossain MJ, Gurley ES, et al. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerg Infect Dis. 2013;19:210-7.
43. Jansen KA. The 2005-2007 Chikungunya epidemic in Reunion: ambiguous etiologies, memories, and meaning-making. Med Anthropol. 2013;32:174-89.
44. Ruiz-Moreno D, Vargas IS, Olson KE, Harrington LC. Modeling dynamic introduction of Chikungunya virus in the United States. PLoS Negl Trop Dis. 2012;6:e1918.
45. Armstrong PM, Andreadis TG. Eastern equine encephalitis virus-old enemy, new threat. N Engl J Med. 2013;368:1670-3.
46. Polio this week - as of July 31, 2013 [online]. Available at: http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 1 August 2013.
47. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013;6, CD004405.
48. Koopmans MM, Brouwer MC, Bijlsma MW, et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis. 2013;57:247-53.
49. Garg RK, Jain A, Malhotra HS, et al. Drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther. 2013;11:605-21.
50. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California encephalitis project, 1998-2000. Clin Infect Dis. 2003;36:731-42.
51. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565-77.
52. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48:2495-501.
53. Aggarwal M, Kak A, Nair D. Have we made any headway in the diagnosis of neurotuberculosis? Place of real time PCR or real time PCR. J Pediatr Infect Dis. 2012;7.
54. Sedlak RH, Jerome KR. Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis. 2013;75:1-4.
55. Kiss MM, Ortoleva-Donnelly L, Beer NR, et al. High-throughput quantitative polymerase chain reaction in picoliter droplets. Anal Chem. 2008;80:8975-81.
56. Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med. 2012;367:2194-203.
57. Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell. 2013;12:677-83.
58. Kerkering TM, Grifasi ML, Baffoe-Bonnie AW, et al. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections. Ann Intern Med. 2013;158:154-61.